Citirik Mehmet
University of Health Sciences, Ankara Ulucanlar Eye Education and Research Hospital, Ulucanlar Cd. No. 59, Altindag, 06240 Ankara, Turkey.
Ther Adv Ophthalmol. 2019 Jul 29;11:2515841419864844. doi: 10.1177/2515841419864844. eCollection 2019 Jan-Dec.
The aim of this article is to determine and compare the platelet activation by three main platelet activation parameters: mean platelet volume, platelet distribution width, and plateletcrit in patients with central retinal vein occlusion and control subjects.
This study included 30 patients with nonischemic central retinal vein occlusion and 30 control subjects. The levels of mean platelet volume, platelet distribution width, and plateletcrit were measured in all groups.
The mean serum level of mean platelet volume was 10.01 ± 0.89 fl in central retinal vein occlusion group and 8.74 ± 1.45 fl in control group. The mean serum level of platelet distribution width was 14.31 ± 1.49% and 11.65 ± 1.81% in central retinal vein occlusion group and control group, respectively. Mean serum plateletcrit value was 0.27 ± 0.07% in central retinal vein occlusion group and 0.23 ± 0.07% in control group. Mean platelet volume, platelet distribution width, and plateletcrit levels were significantly higher in central retinal vein occlusion patients than controls ( < 0.05).
Subclinical platelet activation reflected by mean platelet volume, platelet distribution width, and plateletcrit may have an impact on the genesis of vessel occlusion in central retinal vein occlusion. The results may be important for the clinical management of patients with central retinal vein occlusion.
本文旨在通过三个主要血小板活化参数:平均血小板体积、血小板分布宽度和血小板压积,来测定和比较视网膜中央静脉阻塞患者与对照组的血小板活化情况。
本研究纳入30例非缺血性视网膜中央静脉阻塞患者和30例对照者。测量所有组的平均血小板体积、血小板分布宽度和血小板压积水平。
视网膜中央静脉阻塞组的平均血小板体积血清水平为10.01±0.89fl,对照组为8.74±1.45fl。视网膜中央静脉阻塞组和对照组的血小板分布宽度血清平均水平分别为14.31±1.49%和11.65±1.81%。视网膜中央静脉阻塞组的平均血小板压积血清值为0.27±0.07%,对照组为0.23±0.07%。视网膜中央静脉阻塞患者的平均血小板体积、血小板分布宽度和血小板压积水平显著高于对照组(<0.05)。
平均血小板体积、血小板分布宽度和血小板压积所反映的亚临床血小板活化可能对视网膜中央静脉阻塞的血管阻塞发生有影响。该结果可能对视网膜中央静脉阻塞患者的临床管理具有重要意义。